Latest Insider Transactions at Hims & Hers Health, Inc. (HIMS)
This section provides a real-time view of insider transactions for Hims & Hers Health, Inc. (HIMS). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Hims & Hers Health, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Hims & Hers Health, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 15
2024
|
Lynne Chou O'Keefe Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,044
+50.0%
|
-
|
|
Mar 15
2024
|
Irene Becklund PAO |
SELL
Payment of exercise price or tax liability
|
Direct |
6,397
-32.39%
|
$89,558
$14.63 P/Share
|
|
Mar 15
2024
|
Irene Becklund PAO |
BUY
Exercise of conversion of derivative security
|
Direct |
19,750
+50.0%
|
-
|
|
Mar 15
2024
|
Melissa Baird Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
20,407
-3.65%
|
$285,698
$14.63 P/Share
|
|
Mar 15
2024
|
Melissa Baird Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
51,874
+8.49%
|
-
|
|
Mar 15
2024
|
Garcia Andrea G Perez Director |
BUY
Exercise of conversion of derivative security
|
Direct |
9,122
+14.68%
|
-
|
|
Mar 15
2024
|
Michael Chi Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
27,535
-13.55%
|
$385,490
$14.63 P/Share
|
|
Mar 15
2024
|
Michael Chi Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
57,151
+21.95%
|
-
|
|
Mar 15
2024
|
Andrew Dudum Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
61,539
-54.99%
|
$861,546
$14.63 P/Share
|
|
Mar 15
2024
|
Andrew Dudum Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
111,900
+50.0%
|
-
|
|
Mar 15
2024
|
Patrick Harrison Carroll Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,391
-1.28%
|
$33,474
$14.63 P/Share
|
|
Mar 15
2024
|
Patrick Harrison Carroll Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
31,436
+14.44%
|
-
|
|
Mar 15
2024
|
Alex Bard Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,449
+4.26%
|
-
|
|
Mar 15
2024
|
Ambar Bhattacharyya Director |
BUY
Exercise of conversion of derivative security
|
Direct |
9,122
+11.35%
|
-
|
|
Mar 15
2024
|
David B Wells Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,044
+6.04%
|
-
|
|
Mar 15
2024
|
Oluyemi Okupe Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
38,864
-17.88%
|
$544,096
$14.63 P/Share
|
|
Mar 15
2024
|
Oluyemi Okupe Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
70,729
+24.55%
|
-
|
|
Mar 15
2024
|
Soleil Boughton Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
18,208
-9.71%
|
$254,912
$14.63 P/Share
|
|
Mar 15
2024
|
Soleil Boughton Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
33,232
+15.05%
|
-
|
|
Mar 15
2024
|
Christiane Pendarvis Director |
BUY
Exercise of conversion of derivative security
|
Direct |
15,210
+50.0%
|
-
|
|
Mar 13
2024
|
Soleil Boughton Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
63,621
-29.19%
|
$954,315
$15.17 P/Share
|
|
Mar 13
2024
|
Soleil Boughton Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
63,621
+22.59%
|
$127,242
$2.43 P/Share
|
|
Mar 07
2024
|
Irene Becklund PAO |
SELL
Open market or private sale
|
Direct |
2,747
-100.0%
|
$38,458
$14.19 P/Share
|
|
Mar 07
2024
|
Melissa Baird Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
11,751
-1.14%
|
$164,514
$14.36 P/Share
|
|
Mar 07
2024
|
Melissa Baird Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
11,751
+1.12%
|
$0
$0.4 P/Share
|
|
Mar 06
2024
|
Melissa Baird Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
11,751
-1.14%
|
$152,763
$13.99 P/Share
|
|
Mar 06
2024
|
Melissa Baird Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
11,751
+1.12%
|
$0
$0.4 P/Share
|
|
Mar 05
2024
|
Melissa Baird Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
11,751
-1.14%
|
$164,514
$14.22 P/Share
|
|
Mar 05
2024
|
Melissa Baird Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
11,751
+1.12%
|
$0
$0.4 P/Share
|
|
Mar 04
2024
|
Oluyemi Okupe Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
50,574
-8.82%
|
$657,462
$13.46 P/Share
|
|
Mar 04
2024
|
Oluyemi Okupe Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
40,527
+17.04%
|
$202,635
$5.01 P/Share
|
|
Mar 04
2024
|
Irene Becklund PAO |
SELL
Open market or private sale
|
Direct |
17,930
-86.71%
|
$251,020
$14.5 P/Share
|
|
Mar 04
2024
|
Irene Becklund PAO |
BUY
Exercise of conversion of derivative security
|
Direct |
17,930
+46.44%
|
$161,370
$9.41 P/Share
|
|
Mar 01
2024
|
Irene Becklund PAO |
SELL
Open market or private sale
|
Direct |
2,747
-50.0%
|
$35,711
$13.16 P/Share
|
|
Mar 01
2024
|
Andrew Dudum Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
144,448
-8.28%
|
$1,877,824
$13.07 P/Share
|
|
Mar 01
2024
|
Andrew Dudum Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
240,549
-100.0%
|
$3,127,137
$13.07 P/Share
|
|
Mar 01
2024
|
Andrew Dudum Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
188,896
+43.99%
|
$377,792
$2.43 P/Share
|
|
Feb 29
2024
|
Andrew Dudum Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
577,007
-91.78%
|
$6,924,084
$12.96 P/Share
|
|
Feb 29
2024
|
Andrew Dudum Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
577,007
+47.86%
|
$1,154,014
$2.43 P/Share
|
|
Feb 28
2024
|
David B Wells Director |
SELL
Open market or private sale
|
Direct |
260,000
-64.01%
|
$3,380,000
$13.16 P/Share
|
|
Feb 28
2024
|
Michael Chi Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
47,687
-24.61%
|
$619,931
$13.19 P/Share
|
|
Feb 28
2024
|
Patrick Harrison Carroll Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
20,000
-11.44%
|
$260,000
$13.19 P/Share
|
|
Feb 27
2024
|
Irene Becklund PAO |
SELL
Open market or private sale
|
Direct |
2,747
-33.33%
|
$32,964
$12.08 P/Share
|
|
Feb 15
2024
|
Soleil Boughton Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
5,972
-3.73%
|
$59,720
$10.04 P/Share
|
|
Feb 15
2024
|
Soleil Boughton Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,972
+3.59%
|
$11,944
$2.43 P/Share
|
|
Feb 14
2024
|
Soleil Boughton Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
17,109
-9.98%
|
$171,090
$10.0 P/Share
|
|
Feb 14
2024
|
Soleil Boughton Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
17,109
+9.07%
|
$34,218
$2.43 P/Share
|
|
Feb 14
2024
|
Andrew Dudum Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
77,382
-59.97%
|
$696,438
$9.9 P/Share
|
|
Feb 14
2024
|
Andrew Dudum Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
77,382
+37.49%
|
$154,764
$2.43 P/Share
|
|
Feb 13
2024
|
Andrew Dudum Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
97,208
-65.3%
|
$874,872
$9.58 P/Share
|